Security Snapshot

BIOGEN INC. - COMMON STOCK (BIIB) Institutional Ownership

CUSIP: 09062X103

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

726

Shares (Excl. Options)

72.11MFull value: 72,108,656 · shares · 30 Sep 2026

Price

$225.88

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+5,965
Value change
+$4,694,618
Number of holders
726
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
148,442,922
SEC-reported price per share
$228.90
Insider filing price
$228.90
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • BIIB - BIOGEN INC. - COMMON STOCK is tracked under CUSIP 09062X103.
  • 726 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1,045 to 726 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $30.74BFull value: $30,735,518,159 · USD · 30 Jun 2026
    to
    $16.28BFull value: $16,277,094,791 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 726 institutions filings for Q3 2026.

Open SEC evidence

Security key

09062X103

13F reference period

Q3 2026

13F holders

726

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
BIIB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 12% +10% $3,952,714,750 +$354,673,077 18,294,524 +9.9% FMR LLC 30 Jun 2026
PRIMECAP MANAGEMENT CO/CA/ 10% $2,094,853,956 14,954,697 PRIMECAP MANAGEMENT CO/CA/ 30 Sep 2025
BlackRock, Inc. 8.5% $1,502,927,856 12,506,681 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $2,014,716,401 10,989,562 Vanguard Capital Management 31 Mar 2026
STATE STREET CORP 5.1% +2% $1,732,907,822 +$57,092,467 7,570,589 +3.4% STATE STREET CORPORATION 30 Sep 2026
As of 30 Sep 2026, 726 institutional investors reported holding
72.11MFull value: 72,108,656 · shares · 30 Sep 2026
shares of BIOGEN INC. - COMMON STOCK (BIIB). This represents 49% of the company’s total
148.44MFull value: 148,442,922 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
43%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PRIMECAP MANAGEMENT CO/CA/ 10% 15,197,022 +0.28% 2.1% $3,432,703,328
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 9,670,881 +0.2% 0.05% $2,184,458,600
STATE STREET CORP 5.1% 7,562,205 +3% 0.05% $1,708,150,865
VANGUARD PORTFOLIO MANAGEMENT LLC 4.4% 6,572,163 -0.5% 0.07% $1,484,520,178
GEODE CAPITAL MANAGEMENT, LLC 3% 4,507,404 +1.3% 0.05% $1,014,558,357
WELLINGTON MANAGEMENT GROUP LLP 2.3% 3,458,781 +11% 0.14% $781,269,452
MORGAN STANLEY 1.7% 2,506,410 +3.9% 0.03% $566,148,246
Invesco Ltd. 1.3% 1,972,592 +9.3% 0.03% $445,569,010
Amundi 0.89% 1,316,534 -13% 0.07% $297,378,701
BANK OF AMERICA CORP /DE/ 0.79% 1,174,162 +5.2% 0.02% $265,219,714
DIMENSIONAL FUND ADVISORS LP 0.78% 1,158,052 +0.83% 0.05% $261,588,689
DEUTSCHE BANK AG\ 0.58% 864,971 -3.3% 0.05% $195,379,650
VANGUARD FIDUCIARY TRUST CO 0.56% 834,070 +0.57% 0.04% $188,399,732
Pictet Asset Management Holding SA 0.56% 832,444 -2.3% 0.18% $188,229,218
FIRST TRUST ADVISORS LP 0.54% 797,004 +17% 0.11% $180,027,198
Employees Provident Fund Board 0.53% 783,024 +11% 0.92% $176,869,461
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.52% 773,250 +5% 0.06% $175,773,605
FARALLON CAPITAL MANAGEMENT, L.L.C. 0.46% 680,868 +859% 0.8% $153,794,464
Robeco Institutional Asset Management B.V. 0.44% 656,465 -17% 0.18% $148,282,315
AustralianSuper Pty Ltd 0.42% 622,777 -7.4% 0.58% $140,672,869
Artemis Investment Management LLP 0.39% 581,774 +1.9% 1.1% $131,411,111
Candriam S.C.A. 0.28% 412,472 +7.3% 0.42% $93,509,583
BNP PARIBAS FINANCIAL MARKETS 0.28% 410,030 0.05% $92,617,576
National Pension Service 0.27% 405,153 -0.22% 0.06% $91,515,960
Swiss National Bank 0.27% 403,800 -2.4% 0.05% $91,210,344

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 72,108,656 $16,277,094,791 +$4,694,618 $225.88 726
2026 Q2 142,372,206 $30,735,518,159 +$1,656,891,191 $216.06 1,045
2026 Q1 134,939,450 $24,732,012,332 -$861,910,042 $183.33 1,012
2025 Q4 139,698,197 $24,583,464,503 +$1,492,805,786 $175.99 994
2025 Q3 131,083,249 $18,365,221,765 +$165,798,563 $140.08 894
2025 Q2 129,287,238 $16,238,624,437 +$284,309,412 $125.59 856
2025 Q1 127,028,107 $17,371,280,984 -$578,239,538 $136.84 865
2024 Q4 131,405,263 $20,085,982,511 +$272,768,825 $152.92 861
2024 Q3 128,615,457 $24,913,936,182 -$143,640,766 $193.84 903
2024 Q2 128,193,288 $29,710,612,652 -$84,741,446 $231.82 933
2024 Q1 128,518,741 $27,691,040,526 +$55,007,555 $215.63 932
2023 Q4 127,982,276 $33,111,816,739 +$901,376,761 $258.77 993
2023 Q3 124,470,870 $31,994,071,856 -$470,206,356 $257.01 954
2023 Q2 126,306,466 $35,966,219,806 +$277,366,431 $284.85 994
2023 Q1 125,053,711 $34,758,696,486 +$300,589,329 $278.03 987
2022 Q4 124,528,759 $34,492,440,417 +$242,887,240 $276.92 1,018
2022 Q3 123,323,995 $32,917,825,335 +$384,787,916 $267.00 966
2022 Q2 121,790,135 $24,840,540,438 -$152,960,663 $203.94 911
2022 Q1 122,616,063 $25,827,895,030 -$220,078,557 $210.60 941
2021 Q4 123,500,078 $29,628,123,955 -$101,746,917 $239.92 996
2021 Q3 123,461,166 $34,947,282,206 -$614,669,326 $282.99 1,026
2021 Q2 125,522,812 $43,460,004,330 -$566,581,701 $346.27 1,091
2021 Q1 127,388,312 $35,598,424,357 -$380,775,241 $279.75 1,079
2020 Q4 128,905,111 $31,559,604,046 -$521,085,738 $244.86 1,047
2020 Q3 130,781,613 $37,077,214,726 -$1,220,436,591 $283.68 1,036
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .